… female cancer and the third leading cause of cancer … India, cervical cancer ranks as the
second leading cause of cancer in women. An estimated one-fourth of the world's cervical cancer …

… survival rate for patients with cervical cancer at all stages, and analyze the appropriate stages
for different treatment methods. These may be helpful for clinical treatment and prevention. …

… of clinical specimens have been merged into a cervical cancer … implications of hrHPV testing
and some other biomarkers deduced from this model for cervical screening and the clinical …

… cervical cancer in the past decades by early detection or prevention, cervical cancer remains …
In 2008, over a half million women were diagnosed with cervical cancer, and approximately …

… clinical application (2, 3). Several findings have demonstrated the importance of glycosylation
in the cervical cancer … individual variations between normal and cervical cancer tissues (4). …

… Clearly, the results of CIRCCa provide additional clinical evidence that VEGF-dependent
tumour angiogenesis remains a valid target in cervical cancer and that the need to explore …

… analysis of 16 targetable oncogenic mutations in 285 cervical cancers [18]. In this study,
a larger cohort of patients with cervical cancer (876 patients) were enrolled to explore its …

… 1.5-2.3 to develop this type of cancer. From a practical clinical point of view, we suggest that
as in women with an increased non-genetic risk to develop cervical cancer (eg because of …

… the clinical implications of macrophage-derived angiogenesis in uterine cervical cancers. …
Clinical stages of uterine cervical cancer were assessed according to FIGO classification. Each …

… We review the diagnostic approaches to lymph nodes involvement in cervical cancer. …
tumor marker most commonly used for clinical monitoring of SCC cervical cancer [27,28] and …